Li, Y., Xie, Y., Gong, C., Zhao, Y., Zhang, J., Zhang, S., . . . Wang, B. (2020). Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience. Ther Clin Risk Manag.
Παραπομπή Chicago StyleLi, Yi, et al. "Comparative Treatment Patterns and Outcomes of Fulvestrant Versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience." Ther Clin Risk Manag 2020.
Παραπομπή MLALi, Yi, et al. "Comparative Treatment Patterns and Outcomes of Fulvestrant Versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience." Ther Clin Risk Manag 2020.